Fundraising Fox
DVLP Medicines
Founded 2022 · 11 employees on LinkedIn · 1 known investors
Find your way into DVLP Medicines
413 people in our graph share verified history with the DVLP Medicines team — schools, employers, funds. One of them is your warm intro.
Jason Pontinunlockedknows Jason Paragas · together at DVLP Medicines (overlapped)
knows the team · via Geode Capital Management
×2knows the team · via National Institute of Allergy and Infectious Diseases (NIAID)
×3knows the team · via Lawrence Livermore National Laboratory
×5knows the team · via Social Impact Capital
DVLP is a biotechnology company developing vaccine platforms using artificial intelligence, synthetic biology, and immunology. The company appears to focus on next-generation vaccine development beyond mRNA technologies.
Founders & leadership
DVLP Medicines was founded in 2022 by Patrick Perry and Jason Paragas.
PP
Patrick PerryCo-founder / CFO / GMPatrick Perry served in investment management and business development roles, most recently at Geode Capital where he led institutional client relationships and helped grow assets under management across multiple asset classes. He is now co-founder and CFO of DVLP Medicines, a biotechnology company developing vaccine platforms.
JP
Board
MK
Mehmood KhanChairman of the Board
Investors · 1
DCVC (Data Collective)listed by DCVC (Data Collective)Palo Alto · $5M – $25M
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does DVLP Medicines do?
- DVLP is a biotechnology company developing vaccine platforms using artificial intelligence, synthetic biology, and immunology. The company appears to focus on next-generation vaccine development beyond mRNA technologies.
- Who founded DVLP Medicines?
- DVLP Medicines was founded by Patrick Perry, Jason Paragas in 2022.
- Who are DVLP Medicines's investors?
- DVLP Medicines's investors include DCVC (Data Collective).